A challenging case of cutaneous leishmaniasis with thrombophlebitic complication

A challenging case of cutaneous leishmaniasis with thrombophlebitic complication

Abstract We report a case of cutaneous leishmaniasis caused by Leishmania guyanensis with sporotrichoid lymphocutaneous dissemination of the parasite and thrombophlebitic complication in a 32‐year‐old man who had recently travelled to French Guiana. After initial failure of empirical treatment with...

Full description

Bibliographic Details
Main Authors:	Antoine Willemart, Laura Mengeot, Jean‐Cyr Yombi, Léo Paul Secco, Marie Baeck
Format:	Article
Language:	English
Published:	Wiley 2023-12-01
Series:	JEADV Clinical Practice
Subjects:	L. guyanensis Leishmaniasis liposomal amphotericin B pentavalent antimonials sporotrichoid dissemination thrombophlebitis
Online Access:	https://doi.org/10.1002/jvc2.244

Similar Items

COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
by: Muhammad Farooq, et al.
Published: (2021-02-01)

Visceral Leishmaniasis Treatment, Italy
by: Luigi Gradoni, et al.
Published: (2003-12-01)

Pentavalent Antimonials: New Perspectives for Old Drugs
by: Raul R. Ribeiro, et al.
Published: (2009-06-01)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
by: Valter Viana Andrade-Neto, et al.
Published: (2021-04-01)

Unusual Presentations of Cutaneous Leishmaniasis in an Endemic Area, Kerman Province, Iran
by: Simin Shamsi Meymandi, et al.
Published: (2017-11-01)

Old world cutaneous leishmaniasis in Iran: clinical variants and treatments
by: Alireza Firooz, et al.
Published: (2021-10-01)

Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis
by: Vahid Mashayekhi Goyonlo, et al.
Published: (2014-01-01)

Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial
by: Luciana Mendes, et al.
Published: (2021-02-01)

Comparisso of intralesionally injected Zink sulfate and pentavalent Antimony compound in treatment of acute cutaneous leishmaniasis
by: A.R GHafarinejhad, et al.
Published: (2000-09-01)

Cutaneous sporotrichoid leishmaniasis: An atypical case caused by Leishmania major
by: Adila Bassaid, et al.
Published: (2022-01-01)

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2019-03-01)

Recurrent American Cutaneous Leishmaniasis
by: Jean-Pierre Gangneux, et al.
Published: (2007-09-01)

Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis
by: Santos Mácia A., et al.
Published: (2002-01-01)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
by: Sofia Sales Martins, et al.
Published: (2021-07-01)

High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls
by: Gustavo Adolfo Sierra Romero, et al.
Published: (2003-01-01)

Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis
by: Shirzadi MR
Published: (2019-04-01)

Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
by: Janaína de Pina Carvalho, et al.
Published: (2021-01-01)

Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs
by: Weverson A. Ferreira, et al.
Published: (2014-04-01)

Treatment of visceral leishmaniasis
by: E M Moore, et al.
Published: (2010-01-01)

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
by: Guilherme S. Ramos, et al.
Published: (2022-05-01)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
by: Maria Ubals, et al.
Published: (2021-09-01)

Combining diagnostic procedures for the management of leishmaniasis in areas with high prevalence of Leishmania guyanensis Procedimentos diagnósticos combinados no manejo da leishmaniose em áreas com alta prevalência de Leishmania guyanensis
by: Ednelza de Almeida Benicio, et al.
Published: (2011-12-01)

Mucosal leishmaniasis: the experience of a Brazilian referral center
by: Mariana Junqueira Pedras, et al.

Eficacia y toxicidad de los antimoniales pentavalentes (Glucantime y Pentostam) en un modelo animal de leishmaniasis cutánea americana: aplicación de la luminometría.
by: Hector Hernán Henao, et al.
Published: (2004-12-01)

Distinct plasma chemokines and cytokines signatures in Leishmania guyanensis-infected patients with cutaneous leishmaniasis
by: Tirza Gabrielle Ramos de Mesquita, et al.
Published: (2022-08-01)

Molecular diagnosis and therapy for cutaneous leishmaniasis of a returned traveler from Mexico
by: Pei-Hsuan Tsai, et al.
Published: (2021-12-01)

Visceral leishmaniasis in pregnant women from Rio Grande do Norte, Brazil: A case report and literature review
by: Francielly Tertulino Cunha, et al.
Published: (2019-02-01)

Heat shock protein 70 (HSP70) expression in antimony susceptible/resistant clinical isolates of Leishmania donovani
by: Mahendra Maharjan, et al.
Published: (2015-12-01)

Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
by: Saskia van Henten, et al.
Published: (2023-08-01)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area
by: Daniel Holanda Barroso, et al.
Published: (2022-09-01)

Parto prematuro após uso de antimonial pentavalente: relato de um caso Premature birth after the use of pentavalent antimonial: case report
by: Bruna Pinheiro Silveira, et al.
Published: (2003-07-01)

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
by: Sandip Mukherjee, et al.
Published: (2020-11-01)

Takayasu Arteritis Coexisting with Cutaneous Leishmaniasis
by: Mutong Zhao, et al.
Published: (2023-02-01)

American tegumentary leishmaniasis - a case of therapeutic challenge
by: Daíne Vargas Couto, et al.
Published: (2014-12-01)

Drug resistance in leishmaniasis
by: Jaya Chakravarty, et al.
Published: (2010-01-01)

An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable Um esquema antimonial alternativo para ser empregado na leishmaniose cutânea quando altas doses de antimônio são indesejáveis
by: Manoel Paes de Oliveira-Neto, et al.
Published: (2006-08-01)

Treatment of cutaneous leishmaniasis with combination of allopurinol and low dose of meglumine antimoniate
by: A Momeni, et al.
Published: (2001-03-01)

Visceral Leishmaniasis in Children in Southern Turkey: Evaluation of Clinical and Laboratory Findings and Liposomal Amphotericin B Treatment
by: Barbaros Şahin Karagün, et al.
Published: (2019-06-01)

Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate
by: D.A. Schettini, et al.
Published: (2005-12-01)

Antimonial treatment failure rate in patients with cutaneous leishmaniasis
by: Fariba Jaffary, et al.
Published: (2018-06-01)